Deborah Dillon
- Oncology top 2%
- HER2/EGFR in Cancer Research 13
- Cancer Immunotherapy and Biomarkers 12
- Cancer Cells and Metastasis 8
- Cancer Research top 2%
- Cancer Genomics and Diagnostics 22
- Breast Cancer Treatment Studies 15
-
- Breast Lesions and Carcinomas 9
- Molecular Biology top 5%
- Rehabilitation top 5%
-
- Monoclonal and Polyclonal Antibodies Research 8
-
- Advanced Breast Cancer Therapies 8
- Co-authors
- Lili JiKathleen A. CurtisDavid L. RimmEric R. FearonJosé CostaAndrea L. RichardsonEric P. WinerEric B. Rimm
- Journals
- Cancer Research (10 papers)Journal of Clinical Oncology (8 papers)Proceedings of the National Academy of Sciences (5 papers)
- Partner nations
- United StatesBrazilSpain
In The Last Decade
Deborah Dillon
85 papers receiving 3.6k citations
Hit Papers
Peers
Comparison fields: 5 of 133
- Oncology 1.5k
- Cancer Research 829
- Pathology and Forensic Medicine 553
- Molecular Biology 1.5k
- Rehabilitation 117
Countries citing papers authored by Deborah Dillon
This map shows the geographic impact of Deborah Dillon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah Dillon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah Dillon more than expected).
Fields of papers citing papers by Deborah Dillon
This network shows the impact of papers produced by Deborah Dillon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah Dillon. The network helps show where Deborah Dillon may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Deborah Dillon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 4 | |
| 4 | 2023 | 15 | |
| 5 | 2023 | 0 | |
| 6 | 2022 | 31 | |
| 7 | 2022 | 4 | |
| 8 | 2021 | 18 | |
| 9 | 2021 | 25 | |
| 10 | 2020 | 21 | |
| 11 | 2019 | 25 | |
| 12 | 2019 | 21 | |
| 13 | 2013 | 35 | |
| 14 | 2012 | 6 | |
| 15 | 2010 | 107 | |
| 16 | 2003 | 212 | |
| 17 | 2003 | 43 | |
| 18 | 2002 | 110 | |
| 19 | 2002 | 6 | |
| 20 | 2001 | 25 |
About Deborah Dillon
Deborah Dillon is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 87 papers that have together received 3.7k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (22 papers), Breast Cancer Treatment Studies (15 papers), HER2/EGFR in Cancer Research (13 papers), Cancer Immunotherapy and Biomarkers (12 papers), Breast Lesions and Carcinomas (9 papers), Cancer Cells and Metastasis (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Advanced Breast Cancer Therapies (8 papers). The work is most often cited by research in Oncology (1.5k citations), Cancer Research (829 citations) and Pathology and Forensic Medicine (553 citations). Deborah Dillon has collaborated with scholars based in United States, Brazil and Spain. Frequent co-authors include Lili Ji, Kathleen A. Curtis, David L. Rimm, Eric R. Fearon, José Costa, Andrea L. Richardson, Eric P. Winer, Eric B. Rimm, Thomas G. D'Aquila and Rola A.D. Ghoussoub. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Proceedings of the National Academy of Sciences, Archives of Pathology & Laboratory Medicine and Modern Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.